Joon Lee
Stock Analyst at Truist Securities
(2.95)
# 396
Out of 5,327 analysts
135
Total ratings
52.78%
Success rate
32.15%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VKTX Viking Therapeutics | Reiterates: Buy | 95 75 | 25.43 | 194.93% | 8 | Apr 28, 2025 | |
ARVN Arvinas | Maintains: Buy | 65 21 | 9.14 | 129.76% | 6 | Apr 9, 2025 | |
CORT Corcept Therapeutics | Maintains: Strong Buy | 76 150 | 71.36 | 110.2% | 8 | Mar 31, 2025 | |
NTLA Intellia Therapeutic... | Maintains: Buy | 90 50 | n/a | n/a | 4 | Mar 4, 2025 | |
PRAX Praxis Precision Med... | Maintains: Buy | 175 85 | 36.03 | 135.91% | 5 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 190 200 | n/a | n/a | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 100 120 | 37.67 | 218.56% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 460 520 | 494.43 | 5.17% | 3 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 2.31 | 679.22% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 660 700 | 617.98 | 13.27% | 12 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 16 | 3.28 | 387.8% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 44 57 | 68.5 | -16.79% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 17 36 | 6.76 | 432.54% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 30 36 | 23.56 | 52.8% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 8 | 1.56 | 412.82% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 13 8 | 7.77 | 2.96% | 11 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 17 | 8.98 | 89.31% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 60 60 | n/a | n/a | 2 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 118 90 | 62.84 | 43.22% | 2 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 40 | 2.89 | 1284.08% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 10 10 | n/a | n/a | 7 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 200 | 112.62 | 77.59% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 6 5 | 1.8 | 177.78% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 18 | 3.52 | 411.36% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 22 25 | n/a | n/a | 2 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 280 | 3.53 | 7832.01% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 45 50 | n/a | n/a | 1 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 360 | n/a | n/a | 2 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 27 34 | 21.09 | 61.21% | 1 | Mar 16, 2021 |